重組蛋白
重組蛋白質(zhì)是分析生物相互作用的有用工具。在研究實(shí)驗(yàn)室中使用了大量的重組蛋白質(zhì),包括商業(yè)蛋白質(zhì)和在特定研究項(xiàng)目中生成的蛋白質(zhì)。它們?cè)谠S多應(yīng)用中發(fā)揮著關(guān)鍵作用。
如果您正在尋找具有優(yōu)良質(zhì)量(驗(yàn)證的生物活性,較低的內(nèi)毒素水平和高純度)的重組蛋白質(zhì)來(lái)支持您的研究,您來(lái)對(duì)地方了。
經(jīng)過(guò)16多年的發(fā)展,華美生物已經(jīng)建立了從原核到真核的五大系統(tǒng),用于表達(dá)重組蛋白質(zhì)。我們擁有一系列蛋白質(zhì)表達(dá)和純化技術(shù),包括基于桿狀病毒外膜蛋白(OMP)的蛋白質(zhì)表達(dá)技術(shù),以及膜蛋白表達(dá)技術(shù)等。
產(chǎn)品特點(diǎn)
- 超過(guò)10,000種重組蛋白覆蓋大多數(shù)基因/靶點(diǎn);
- 5種表達(dá)系統(tǒng),包括大腸桿菌(E.coli)、酵母、桿狀病毒感染的昆蟲(chóng)細(xì)胞、哺乳動(dòng)物細(xì)胞和體外大腸桿菌。而體外大腸桿菌表達(dá)系統(tǒng)是華美生物的獨(dú)特表達(dá)系統(tǒng)。與傳統(tǒng)蛋白表達(dá)系統(tǒng)相比,體外大腸桿菌省略了許多過(guò)程,如質(zhì)粒轉(zhuǎn)化、細(xì)胞培養(yǎng)、收集、破碎和離心等,大大提高了工作效率。
- 多種標(biāo)簽,包括His、GST、Flag、MBP等。
- 廣泛應(yīng)用,包括抗原、細(xì)胞分析、結(jié)合分析/蛋白質(zhì)相互作用、細(xì)胞培養(yǎng)-無(wú)血清培養(yǎng)基、藥物相關(guān)研究、體外酶活性、ELISA標(biāo)準(zhǔn)及其原料、體內(nèi)研究、質(zhì)譜標(biāo)準(zhǔn)、蛋白芯片、SDS-PAGE控制、蛋白質(zhì)結(jié)構(gòu)分析(晶體/電子顯微鏡)。
- 多種物種,包括人類(lèi)、小鼠、大鼠、兔子、豚鼠、雞、猴子、豬等。
- 無(wú)動(dòng)物副產(chǎn)品的動(dòng)物源性重組蛋白質(zhì)。華美生物已開(kāi)發(fā)出無(wú)動(dòng)物副產(chǎn)品接觸的重組蛋白質(zhì)產(chǎn)品線(xiàn)。
重組蛋白目錄
以下是所有重組蛋白的目錄。您可以在目錄中找到適合您研究的蛋白質(zhì),或在本網(wǎng)站頭部的搜索框中搜索它們。
如果您找不到您需要的抗體,請(qǐng)查看華美生物蛋白質(zhì)定制服務(wù)。
通過(guò)選擇目標(biāo)名稱(chēng)的首字母瀏覽產(chǎn)品。
產(chǎn)品名稱(chēng) | 貨號(hào) | 規(guī)格 |
---|---|---|
Recombinant Pongo abelii Exportin-T (XPOT), partial | CSB-YP719205PYX CSB-EP719205PYX CSB-BP719205PYX CSB-MP719205PYX CSB-EP719205PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Molybdopterin synthase catalytic subunit (MOCS2) | CSB-YP719206PYX CSB-EP719206PYX CSB-BP719206PYX CSB-MP719206PYX CSB-EP719206PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Protein FAM135A (FAM135A), partial | CSB-YP719207PYX CSB-EP719207PYX CSB-BP719207PYX CSB-MP719207PYX CSB-EP719207PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Pre-mRNA-splicing factor CWC22 homolog (CWC22), partial | CSB-YP719208PYX CSB-EP719208PYX CSB-BP719208PYX CSB-MP719208PYX CSB-EP719208PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii FERM, RhoGEF and pleckstrin domain-containing protein 1 (FARP1), partial | CSB-YP719209PYX CSB-EP719209PYX CSB-BP719209PYX CSB-MP719209PYX CSB-EP719209PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii RNA polymerase-associated protein RTF1 homolog (RTF1), partial | CSB-YP719210PYX CSB-EP719210PYX CSB-BP719210PYX CSB-MP719210PYX CSB-EP719210PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Glycosyltransferase 1 domain-containing protein 1 (GLT1D1) | CSB-YP719211PYX CSB-EP719211PYX CSB-BP719211PYX CSB-MP719211PYX CSB-EP719211PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Lysosomal-associated transmembrane protein 4A (LAPTM4A), partial | CSB-YP719212PYX1 CSB-EP719212PYX1 CSB-BP719212PYX1 CSB-MP719212PYX1 CSB-EP719212PYX1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Endonuclease 8-like 2 (NEIL2) | CSB-YP719213PYX CSB-EP719213PYX CSB-BP719213PYX CSB-MP719213PYX CSB-EP719213PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 (B3GALNT1), partial | CSB-YP719214PYX CSB-EP719214PYX CSB-BP719214PYX CSB-MP719214PYX CSB-EP719214PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Ribosome biogenesis protein BRX1 homolog (BRIX1) | CSB-YP719215PYX CSB-EP719215PYX CSB-BP719215PYX CSB-MP719215PYX CSB-EP719215PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Pyrroline-5-carboxylate reductase 2 (PYCR2) | CSB-YP719216PYX CSB-EP719216PYX CSB-BP719216PYX CSB-MP719216PYX CSB-EP719216PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Target of EGR1 protein 1 (TOE1), partial | CSB-YP719217PYX CSB-EP719217PYX CSB-BP719217PYX CSB-MP719217PYX CSB-EP719217PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Protein kish-B (TMEM167B), partial | CSB-YP719218PYX CSB-EP719218PYX CSB-BP719218PYX CSB-MP719218PYX CSB-EP719218PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Uncharacterized protein CXorf40 homolog | CSB-YP719219PYX CSB-EP719219PYX CSB-BP719219PYX CSB-MP719219PYX CSB-EP719219PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Ribosome maturation protein SBDS (SBDS) | CSB-YP719220PYX CSB-EP719220PYX CSB-BP719220PYX CSB-MP719220PYX CSB-EP719220PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (DHX15), partial | CSB-YP719221PYX CSB-EP719221PYX CSB-BP719221PYX CSB-MP719221PYX CSB-EP719221PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Transcription factor CP2-like protein 1 (TFCP2L1) | CSB-YP719222PYX CSB-EP719222PYX CSB-BP719222PYX CSB-MP719222PYX CSB-EP719222PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Cullin-5 (CUL5), partial | CSB-YP719223PYX CSB-EP719223PYX CSB-BP719223PYX CSB-MP719223PYX CSB-EP719223PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Pongo abelii Ectonucleotide pyrophosphatase/phosphodiesterase family member 6 (ENPP6) | CSB-YP719224PYX CSB-EP719224PYX CSB-BP719224PYX CSB-MP719224PYX CSB-EP719224PYX-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
有用資源
什么是重組蛋白?
重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。
第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。
第二條:如何選擇合適的表達(dá)載體?
表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。
根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。
引用資料
Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023
Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023
Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023
Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023
Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022